Olugbeminiyi Fadeyi

Statistics

Publications

Citations

3.3K

H-Index

Active since

2008

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Pfizer (United States)

Vanderbilt University

Princeton University

United States Military Academy

Olugbeminiyi Fadeyi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, drug discovery, and natural sciences.

ORCID

Publications per year

2008–2024

Publications

Microenvironment mapping via Dexter energy transfer on immune cells

Jacob B. Geri, James V. Oakley, Tamara Reyes Robles et al. · Science · 2020 · 460 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Mediator kinase inhibition further activates super-enhancer-associated genes in AML

Henry E. Pelish, Brian B. Liau, I Niţulescu et al. · Nature · 2015 · 405 citations · Full text

Medicine, Cancer Biology, Molecular Biology +14

Strain-Release Heteroatom Functionalization: Development, Scope, and Stereospecificity

Justin M. Lopchuk, Kasper Fjelbye, Yu Kawamata et al. · Journal of the American Chemical Society · 2017 · 344 citations · Full text

Pharmacy, Medicinal Chemistry, Bioisosterism +14

Modular radical cross-coupling with sulfones enables access to sp <sup>3</sup> -rich (fluoro)alkylated scaffolds

Rohan R. Merchant, Jacob T. Edwards, Tian Qin et al. · Science · 2018 · 214 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

Visible‐Light‐Initiated Manganese Catalysis for C−H Alkylation of Heteroarenes: Applications and Mechanistic Studies

Philippe Nuhant, Martins S. Oderinde, Julien Genovino et al. · Angewandte Chemie International Edition · 2017 · 186 citations

Natural Sciences, Chemistry, Medicinal Chemistry +17

1–5 of 41